Title | Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population |
Author | |
Corresponding Author | Song,Jian |
Publication Years | 2022
|
DOI | |
Source Title | |
EISSN | 1178-7066
|
Volume | 15Pages:827-842 |
Abstract | Background: ZBTB20 was overexpressed in esophageal cancer (EC). The study aimed to identify genotypes of ZBTB20 polymorph-isms and their correlation with EC occurrence in a Chinese Han population. Methods: Four single nucleotide polymorphisms (SNPs) in ZBTB20 were randomly selected for genotyping through Agena MassARRAY system among 525 EC patients and 522 healthy controls. Multiple genetic models were applied to assess the association of ZBTB20 polymorphisms with EC susceptibility by calculating odds ratios (ORs) with 95% confidence intervals (CIs). Results: Rs10934270 was associated with lower EC susceptibility (OR = 0.64, p = 0.004) with statistical power >90% in overall analysis. Specifically, the correlation of rs10934270 with EC susceptibility was found in subgroups including patients with esophageal squamous cell carcinoma (ESCC), males, subjects aged ≤65 years, subjects with BMI ≤ 24 kg/m, and smokers. Rs9841504 might be a risk-increasing factor for ESCC. Moreover, rs9288999 in subjects aged ≤65 years and rs73230612 in females were related to lower EC risk. Conclusion: Our research is the first to report that ZBTB20 rs10934270 is associated with reduced EC susceptibility in the Chinese Han population. These data provide a scientific basis for understanding the influence of the ZBTB20 gene on EC occurrence. |
Keywords | |
URL | [Source Record] |
Indexed By | |
Language | English
|
SUSTech Authorship | Corresponding
|
Funding Project | 2020 Hainan Province Major Science and Technology Plan Project[ZDKJ202005]
|
WOS Research Area | Pharmacology & Pharmacy
|
WOS Subject | Pharmacology & Pharmacy
|
WOS Accession No | WOS:000856405300001
|
Publisher | |
Scopus EID | 2-s2.0-85138523393
|
Data Source | Scopus
|
Citation statistics |
Cited Times [WOS]:0
|
Document Type | Journal Article |
Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/402771 |
Department | Southern University of Science and Technology Hospital |
Affiliation | 1.Department of Gastrointestinal Surgery,Hainan Cancer Hospital,Haikou,570100,China 2.Department of Gastroenterology,Hainan Cancer Hospital,Haikou,570100,China 3.Digestive Endoscopy Center,Hainan Cancer Hospital,Haikou,570100,China 4.Department of Gastroenterology,Southern University of Science and Technology Hospital,Shenzhen,518000,China 5. |
Corresponding Author Affilication | Southern University of Science and Technology Hospital |
Recommended Citation GB/T 7714 |
Yu,Shuyong,Yuan,Guihong,Hu,Feixiang,et al. Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population[J]. Pharmacogenomics and Personalized Medicine,2022,15:827-842.
|
APA |
Yu,Shuyong.,Yuan,Guihong.,Hu,Feixiang.,Li,Yongyu.,Chen,Zhuang.,...&Song,Jian.(2022).Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population.Pharmacogenomics and Personalized Medicine,15,827-842.
|
MLA |
Yu,Shuyong,et al."Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population".Pharmacogenomics and Personalized Medicine 15(2022):827-842.
|
Files in This Item: | There are no files associated with this item. |
|
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment